Predicting Opioid Use Disorder and Associated Risk Factors in a Medicaid Managed Care Population
Overview
Affiliations
Objectives: Medicaid managed care organizations are developing comprehensive strategies to reduce the impact of opioid use disorder (OUD) among their members. The goals of this study were to develop and validate a predictive model of OUD and to predict future OUD diagnosis, resulting in proactive, person-centered outreach.
Study Design: We utilized machine learning methodology to select a multivariate logistic regression and identify predictors.
Methods: Using 2016-2018 data, we used a staged approach to test and validate the predictive accuracy of our model. We identified OUD, the dependent variable, using an industry-standard definition. We included a series of patient demographic, chronic condition, social determinants of health (SDOH), opioid-related, and health utilization indicators captured in administrative data.
Results: Caucasian (odds ratio [OR], 1.65), male (OR, 1.57), and younger (aged 40-64 years compared with 18-39 years: OR, 0.75) members had greater odds of being diagnosed with an OUD. Members with an SDOH vulnerability had 26% higher odds than those without a documented issue. From a prescribing perspective, we found that having an opioid dose of 120 morphine milligram equivalents and contiguous 5-day supply increased odds of OUD by 1.87 times, and an opioid supply of 30 days or longer increased the odds of OUD by 1.56 times.
Conclusions: We built the necessary machine learning infrastructure to identify members with greater than 50% probability of developing OUD. The generated list strategically informs and guides person-centered care and interventions. Through application of these results, we strive to proactively reduce OUD-related structural barriers and prevent OUD from occurring.
A systematic review of machine learning applications in predicting opioid associated adverse events.
Ramirez Medina C, Benitez-Aurioles J, Jenkins D, Jani M NPJ Digit Med. 2025; 8(1):30.
PMID: 39820131 PMC: 11739375. DOI: 10.1038/s41746-024-01312-4.
Lewandrowski K, Sharafshah A, Elfar J, Schmidt S, Blum K, Wetzel F Cell Mol Neurobiol. 2024; 44(1):47.
PMID: 38801645 PMC: 11129978. DOI: 10.1007/s10571-024-01466-5.
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose.
Song S, Dandapani H, Estrada R, Jones N, Samuels E, Ranney M J Addict Med. 2024; 18(3):218-239.
PMID: 38591783 PMC: 11150108. DOI: 10.1097/ADM.0000000000001276.
He Z, Pfaff E, Guo S, Guo Y, Wu Y, Tao C Yearb Med Inform. 2023; 32(1):253-263.
PMID: 38147867 PMC: 10751148. DOI: 10.1055/s-0043-1768732.
Cartus A, Samuels E, Cerda M, Marshall B Addiction. 2023; 118(6):1167-1176.
PMID: 36683137 PMC: 10175167. DOI: 10.1111/add.16133.